Sort
10,766 grants matching “checkpoint inhibitor”
DNA TOPOISOMERASES &LATE CELL CYCLE CHECKPOINTS
$3,065University Of Calif-Los Alamos Nat Lab · P41 · FY2000 · RR
Molecular engineering and systematic evaluation of bispecific aptamers to develop potent and efficacious therapies for the immunomodulation of Non-Small Cell Lung Cancer
$3,000Brian J Thomas · University Of Missouri-Columbia · F30 · FY2025 · CA
p27pTpT drives cancer-promoting inflammation and shapes the tumor microenvironment (TME) toward a more tumor-permissive state in vivo
$3,000Seyedehfatemeh Razavipour · Georgetown University · F99 · FY2025 · CA
Program 4: Leukemia
$2,949David Marc Weinstock · Dana-Farber Cancer Inst · P30 · FY2020 · CA
Program 30: Neuro-Oncology
$2,948Charles Stiles · Dana-Farber Cancer Inst · P30 · FY2020 · CA
Signal Transduction Research Program
$2,857Daniel Peter Petrylak · Yale University · P30 · FY2018 · CA
Cancer Immunology Research Program
$2,857Lieping Chen · Yale University · P30 · FY2018 · CA
Cancer Immunology Research Program
$2,683Lieping Chen · Yale University · P30 · FY2018 · CA
Signal Transduction Research Program
$2,682Daniel Peter Petrylak · Yale University · P30 · FY2018 · CA
Identifying Effective Immune Checkpoint Therapy Strategies in Triple Negative Breast Cancer
$2,528Daniel Patrick Hollern · Univ Of North Carolina Chapel Hill · F32 · FY2017 · CA
BIOCHEMICAL STUDIES OF HUMAN DNA POLYMERASE DELTA
$2,425Marietta Y. Lee · University Of Washington · P41 · FY2010 · RR
Translational & Clinical Research (TACR) Program
$2,399Muneesh Tewari · University Of Michigan At Ann Arbor · P30 · FY2018 · CA
Cancer Immunology Program - 03
$2,068Drew M. Pardoll · Johns Hopkins University · P30 · FY2018 · CA
Breast and Ovarian Cancer Program - 08
$2,067Vered Stearns · Johns Hopkins University · P30 · FY2018 · CA
MRA Melanoma Models Workshop
$2,000Marc S Hurlbert · Melanoma Research Alliance Foundation · R13 · FY2020 · CA
Robust Predictor of Breast Cancer Risk
$2,000Harry Ostrer · Morgan And Mendel Genomics, Inc. · R41 · FY2018 · CA
Phase II Clinical Trial of G207 HSV To Treat Children with High Grade Gliomas
$1,625George Yancey Gillespie · Treovir, Inc · R44 · FY2022 · CA
Program 4: Leukemia
$1,602Benjamin Levine Ebert · Dana-Farber Cancer Inst · P30 · FY2018 · CA
Program 30: Neuro-Oncology
$1,602Charles Stiles · Dana-Farber Cancer Inst · P30 · FY2018 · CA
Personalized precision dosing of biologic therapies in oncology
$1,450Bradley T Messmer · Abreos Biosciences, Inc. · R44 · FY2019 · CA
Characterization of Altered Immunity in Patients with Inflammatory Arthritis Induced by Immune Checkpoint Inhibitor Therapy
$1,000Sang Taek Kim · Yale University · K08 · FY2024 · AR
Human Immune Monitoring Shared Resource
$3Richard D Schulick · University Of Colorado Denver · P30 · FY2022 · CA
Targeting Unique Myeloid Populations to Overcome Anti-PD-1 Resistance Conferred by Specific Cancer Mutations
$1Brian C Miller · Harvard Medical School · K08 · FY2021 · CA
Adoptive T Cell Therapy for Pancreatic Cancer
$1Cassian Yee · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Center for Lupus Research
$1Maria Virginia Pascual · Baylor Research Institute · P50 · FY2009 · AR